论文部分内容阅读
目的:探讨输尿管癌保肾手术的效果和复发情况。方法:回顾性分析19例输尿管癌保肾手术的临床资料,7例行输尿管病灶部分切除术,9例行输尿管末端及膀胱袖口状切除、输尿管膀胱再植术,3例经输尿管镜行肿瘤电灼。术后均行膀胱灌注化疗。结果:本组中18例为移行细胞癌,1例鳞癌。术后15例获得随访6个月～5年。2例分别于术后7个月及2年同侧输尿管复发;3例术后3个月～3年发现膀胱移行细胞癌;1例于术后1年发现对侧上尿路肿瘤;1例鳞癌患者术后5个月发现肺部转移,术后11个月死亡。结论:输尿管癌为少见尿路上皮肿瘤,保肾手术有复发的风险,需进行随访。但对早期、低级别原发性输尿管肿瘤,保肾手术良好。
Objective: To investigate the effect and recurrence of ureteric nephrectomy. Methods: A retrospective analysis of 19 cases of ureteral cancer with kidney surgery clinical data, 7 cases of partial ureteral resection, 9 cases of distal ureter and cuff resection, ureter bladder replantation, 3 cases of ureteral tumor tumor electricity Burning Postoperative bladder perfusion chemotherapy. Results: In this group, 18 cases were transitional cell carcinoma and 1 case squamous cell carcinoma. Fifteen patients were followed up for 6 months to 5 years. 2 cases of ipsilateral ureteral recurrence at 7 months and 2 years respectively, 3 cases of transitional cell carcinoma of the bladder at 3 months to 3 years after operation, 1 case of contralateral upper urinary tract tumor at 1 year after operation and 1 case Patients with squamous cell carcinoma were found to have lung metastases 5 months after surgery and died 11 months after surgery. Conclusions: Ureteral cancer is a rare urothelial cancer. The risk of recurrence due to kidney-invading surgery needs to be followed up. But for early, low-grade primary ureteral tumors, kidney surgery is good.